MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

Many superheroes have some distinctive traits that we regularly connect with them. Some have their symbols, others specific weapons, and as for Iron Man, he gets most recognized by an arc reactor. It ...

Noblis MSD is a subsidiary of Noblis, an independent, nonprofit organization with a proud tradition of serving federal clients objectively and with the highest caliber of scientific and technical ...